StonvexLoading…
StonvexStonvexStonvexCore line items from NVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.89B | $3.01B | $2.67B | $2.30B |
Operating Income | $616.80M | $527.10M | $462.70M | $309.00M |
Net Income | $710.20M | $331.80M | $567.10M | $399.80M |
EPS (Diluted) | $4.31 | $1.97 | $3.37 | $2.38 |
Total Assets | $6.85B | $6.73B | $6.16B | $4.90B |
Total Liabilities | $3.12B | $3.50B | $3.02B | $2.17B |
Cash & Equivalents | $237.50M | $131.20M | $185.10M | $297.50M |
Free Cash Flow OCF − CapEx | $371.90M | $569.10M | $462.50M | $354.10M |
Shares Outstanding | 164.60M | 168.20M | 168.20M | 168.30M |